Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644949
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet UniversityNot Yet RecruitingNot Applicable
NCT07644949Not Yet Recruiting
Not Applicable
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet Univer...
NCT07644832
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII DeficiencyShanghai RAAS Blood Products Co., Ltd.RecruitingPhase 1
NCT07644832Recruiting
Phase 1
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tol...Shanghai RAAS Blood Produ...
NCT07644676
The Impact of Adhesion Strategy on the Clinical Performance Of Indirect Dental RestorationsMalmö UniversityEnrolling By InvitationNot Applicable
NCT07644676Enrolling By Invitation
Not Applicable
The Impact of Adhesion Strategy on the Clinical Performance Of Indirect Dental R...Malmö University
NCT07643831
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.Unknown
NCT07643831Unknown
—
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2-...Genentech, Inc.
NCT07645794
Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FFCapital Medical UniversityNot Yet Recruiting
NCT07645794Not Yet Recruiting
—
Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in C...Capital Medical Universit...
NCT07643974
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDMedstar Health Research InstituteNot Yet RecruitingEarly Phase 1
NCT07643974Not Yet Recruiting
Early Phase 1
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDMedstar Health Research I...
NCT07644390
Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort StudySixth Affiliated Hospital, Sun Yat-sen UniversityCompleted
NCT07644390Completed
—
Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal...Sixth Affiliated Hospital...
NCT07644559
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerVerastem, Inc.RecruitingPhase 2
NCT07644559Recruiting
Phase 2
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerVerastem, Inc.
NCT07646561
Transcranial Doppler in Preeclampsia and Its Complications.University Tunis El ManarCompleted
NCT07646561Completed
—
Transcranial Doppler in Preeclampsia and Its Complications.University Tunis El Manar
NCT07646015
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic DisordersJSS Medical College HospitalCompleted
NCT07646015Completed
—
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, L...JSS Medical College Hospi...
NCT07644728
Sleep Quality and Biomarkers in Adolescent Girls With Anorexia NervosaUniversity Hospital of SplitNot Yet Recruiting
NCT07644728Not Yet Recruiting
—
Sleep Quality and Biomarkers in Adolescent Girls With Anorexia NervosaUniversity Hospital of Sp...
NCT07645118
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te VuongNot Yet RecruitingPhase 2
NCT07645118Not Yet Recruiting
Phase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07645014
Comparative Effects of Neurodynamic Stretch and Myofascial Pain Release in Polycystic Ovarian Syndrome.Riphah International UniversityRecruitingNot Applicable
NCT07645014Recruiting
Not Applicable
Comparative Effects of Neurodynamic Stretch and Myofascial Pain Release in Polyc...Riphah International Univ...
NCT07646548
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron PharmaceuticalsNot Yet RecruitingPhase 1
NCT07646548Not Yet Recruiting
Phase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Be...Regeneron Pharmaceuticals
NCT07645339
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier RepairL'OrealActive Not RecruitingNot Applicable
NCT07645339Active Not Recruiting
Not Applicable
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier...L'Oreal
NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPharmaMarRecruitingPhase 1
NCT07644039Recruiting
Phase 1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advan...PharmaMar
NCT07645716
Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic OncologyFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07645716Not Yet Recruiting
—
Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards...Fondazione Policlinico Un...
NCT07644221
Feasibility and Effects of Noninvasive Brain Stimulation on Pain Perception in People With FibromyalgiaDepartment of Anesthesiology & Perioperative Medicine, University of PittsburghNot Yet RecruitingNot Applicable
NCT07644221Not Yet Recruiting
Not Applicable
Feasibility and Effects of Noninvasive Brain Stimulation on Pain Perception in P...Department of Anesthesiol...
NCT07644585
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and NeckIBA Proton Therapy, Inc.Not Yet RecruitingNot Applicable
NCT07644585Not Yet Recruiting
Not Applicable
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Ca...IBA Proton Therapy, Inc.
Result Breakdown
Not yet recruiting10 (50%)
Recruiting4 (20%)
Completed3 (15%)
Enrolling by invitation1 (5%)
Unknown1 (5%)
Active, not recruiting1 (5%)
Not Specified8 (40%)
not_applicable6 (30%)
Phase 13 (15%)
Phase 22 (10%)
Early Phase 11 (5%)